PLOD1 and ovarian hyperstimulation syndrome: GnRH-ant directly inhibits gonadotropin release and prevents LH surges, reducing the incidence of OHSS by 10.0% compared to gonadotropin-releasing hormone agonist (GnRH-a) protocols (8).